Development of a Non-invasive Prenatal Test
NCT01451684 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15000
Last updated 2020-04-30
Summary
This is an observational study to aid in the development of a non-invasive prenatal test that may be used to aid in detection of fetal aneuploidy. Pregnant women will be recruited and asked to provide a blood sample to be used for general test development purposes.
Conditions
- Pregnancy
Sponsors & Collaborators
-
Cindy Cisneros
lead INDUSTRY
Principal Investigators
-
Tracy Roberts · Ariosa Diagnostics
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-06-30
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- United States
Study Locations
More Related Trials
-
Investigation of the Impact of Noninvasive Prenatal Testing for Fetal Aneuploidy on Utilization of Prenatal Diagnostic Procedures and Pregnant Women's Views
NCT01708746 ·Status: COMPLETED
-
Non-Invasive Screening for Fetal Aneuploidy
NCT02317965 ·Status: UNKNOWN
-
Cell-based Non-invasive Prenatal Testing as an Alternative to Invasive Chorionic Villus Sampling
NCT05453474 ·Status: COMPLETED ·Phase: NA
-
Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
NCT00770458 ·Status: COMPLETED
-
A Study Collecting Blood Samples From Pregnant Women to Aid in the Development of a Noninvasive Prenatal Test
NCT03620110 ·Status: COMPLETED
-
Prevalence of Ambivalence Regarding Prenatal Testing
NCT00342069 ·Status: COMPLETED
-
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
NCT01852708 ·Status: COMPLETED
-
Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood
NCT04285814 ·Status: COMPLETED
-
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
NCT02109770 ·Status: COMPLETED
-
Ensuring Patients' Informed Access to Noninvasive Prenatal Testing
NCT03420274 ·Status: COMPLETED ·Phase: NA
-
Validate Non-invasive Prenatal Tests for the Detection of Chromosomal Abnormalities
NCT05618431 ·Status: RECRUITING ·Phase: NA
-
Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies
NCT01052688 ·Status: COMPLETED
-
Comparison of Aneuploidy Risk Evaluations
NCT01663350 ·Status: COMPLETED
-
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
NCT04595201 ·Status: RECRUITING
-
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
NCT01597063 ·Status: COMPLETED
-
Use of a Novel Computerized Decision Aid for Prenatal Aneuploidy Screening
NCT02991729 ·Status: COMPLETED ·Phase: NA
-
Fetal Cell Analysis From Maternal Blood
NCT05671744 ·Status: UNKNOWN ·Phase: NA
-
Prenatal Test for Fetal Aneuploidy Detection
NCT01256606 ·Status: COMPLETED
-
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
NCT01429389 ·Status: RECRUITING
-
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
NCT01555346 ·Status: COMPLETED
-
Measuring hCG Levels in Pregnant Women
NCT02763176 ·Status: COMPLETED
-
Cell- Based Noninvasive Prenatal Testing (NIPT): Single Cell Prenatal Diagnosis (SCPD)
NCT05076734 ·Status: COMPLETED ·Phase: NA
-
Down Syndrome - Comparison of Screening Methods in the 1st and 2nd Trimesters
NCT00006445 ·Status: UNKNOWN ·Phase: NA
-
Biochemical Markers and 2 and 3D Ultrasound to ID Maternal & Fetal Complications
NCT01404221 ·Status: TERMINATED
-
Noninvasive Prenatal Diagnosis: Using Fetal Cells From Maternal Blood
NCT00064597 ·Status: UNKNOWN